Fig. 12

Evaluation of the potential immunoprotective effect of the CNSL derivatives by measuring the levels of cytosine IL-6 production in the supernatant at 6 h (a) and 24 h (b) post-stimulus. NT- untreated cells; LPS - LPS-stimulated cells; LDT11 - cells treated with LDT11 and then with LPS; AAS - cells treated with commercial acetylsalicylic acid and then with LPS; DEX - cells treated with the commercial anti-inflammatory Dexamethasone and then with LPS. All data are from at least three independent experiments, *p < 0.05, statistically different compared with cells LPS-stimulated